Stay updated on Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial
Sign up to get notified when there's something new on the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page.

Latest updates to the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 is now displayed in the page footer, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added, and the notices about government funding status and the older Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now shows a site revision label updated to v3.4.1 (replacing v3.4.0) and adds a government funding notice banner about NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary toggle (Show glossary) to the page and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' with a new 'Revision: v3.4.0'; the previous QC phrasing and the 'No FEAR Act data' label were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; there are no changes to the study details, layout, or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations section reorganized into a consolidated 'Locations' list including Arizona, Iowa, New York, Virginia, and Victoria, replacing separate 'XYZ Locations' headings; revision updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page.